Stay updated on Pembrolizumab Combo in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Metastatic NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The NIH grant/contract note was added to the study identifiers, and the page revision was updated to v3.6.6 (replacing v3.6.5).
    Difference
    0.1%
    Check dated 2026-08-29T18:59:27.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.4 to v3.6.5, signaling a minor update to the study record. This does not imply a substantive change to the study details.
    Difference
    0.0%
    Check dated 2026-08-08T11:27:22.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Lung cancer and the related topics section, including MedlinePlus Genetics, were removed from the page content. This changes the list of linked topics shown but does not alter the study's design, endpoints, or enrollment information.
    Difference
    0.1%
    Check dated 2026-08-01T11:08:14.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The page now lists Lung cancer and related topics, and adds a MedlinePlus Genetics reference. The revision tag was updated from v3.6.3 to v3.6.4.
    Difference
    0.1%
    Check dated 2026-07-25T06:39:49.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.2 to v3.6.3 on the page, indicating a small CMS or rendering update. The study details themselves appear unchanged.
    Difference
    0.0%
    Check dated 2026-07-03T21:45:23.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.6.2, replacing v3.6.0, indicating a maintenance/version update to the page.
    Difference
    0.0%
    Check dated 2026-06-26T20:45:01.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic NSCLC Clinical Trial page.